Skip to Content
Morningstar

Invesco Dorsey Wright SmallCap Momt ETF DWAS

Morningstar Medalist Rating
Medalist Rating as of | See Invesco Investment Hub

Morningstar’s Analysis DWAS

Will DWAS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable DWAS’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the DWAS management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of DWAS’s parent organization’s priorities and whether they’re in line with investors’ interests.

A sound investment process and strong management team underpin Invesco Dorsey Wright SmallCap Momt ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DWAS

More DWAS Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 15.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Modine Manufacturing Co

1.81 17.0 Mil
Consumer Cyclical

Tidewater Inc

1.67 15.7 Mil
Energy

Sterling Infrastructure Inc

1.64 15.5 Mil
Industrials

Transcat Inc

1.58 14.8 Mil
Industrials

Soleno Therapeutics Inc

1.49 14.0 Mil
Healthcare

SPX Technologies Inc

1.49 14.0 Mil
Industrials

Powell Industries Inc

1.42 13.4 Mil
Industrials

Limbach Holdings Inc

1.39 13.0 Mil
Industrials

Abercrombie & Fitch Co Class A

1.30 12.3 Mil
Consumer Cyclical

ADMA Biologics Inc

1.29 12.1 Mil
Healthcare